EDMONTON, Alberta, Nov. 29 /PRNewswire-FirstCall/ -- Medical Services International Inc. is pleased to announce that it has received additional VScan HIV test kit orders from China. In addition to the VScan HIV test kits required by its existing contracts, the Company has been asked to supply an additional 200,000 VScan HIV test kits by January 15, 2006. The Company has indicated that it has the capacity and has agreed to supply the additional kits. Production will be completed out of the company’s India facility.
This unexpected order will result in additional revenue in excess of $400,000 US. This is in addition to the existing revenue projections of $1,630,000 US for the third quarter. The company is also continuing with its program to obtain regulatory approval of all VScan products in additional countries where market studies show that there will be a demand for the VScan products. The inquiries that the company continues to receive about the VScan products is substantial. The accuracy of the VScan HIV test kit using “whole” blood continues to demonstrate high (99.6%) sensitivity and specificity regardless of how difficult the testing conditions. It requires no medical facilities or medical personnel to do the testing.
About VScan
The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada.
Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol “MSITF”. For further information, please contact Robert Talbot at (780) 430 6363 or media contact Bill Whitehead at (416) 822 5883 or http://www.medicalservicesintl.com or http://www.minerva-biotech.com .
NOTE: Certain statements in this press release are “forward-looking statements” within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and filings with regulatory bodies
Medical Services International Inc.
CONTACT: Robert Talbot, +1-780-430-6363, or Bill Whitehead,+1-416-822-5883, both for Medical Services International Inc.
